Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.
Catheter Cardiovasc Interv. 2011 Apr 1;77(5):634-41. doi: 10.1002/ccd.22729. Epub 2011 Mar 8.
To compare in-hospital outcomes of a large cohort of very elderly patients (age ≥ 85 years) with younger patients (age < 85 years) undergoing percutaneous coronary intervention (PCI) for all indications at our institution.
Interventionist cardiologists are often reluctant to undertake PCI in very elderly patients due to the perception of poor outcome in this high-risk cohort. However, the prognostic significance of advanced age itself is not clear.
Baseline clinical, angiographic and procedural variables, and in-hospital outcome data were entered into a prospective registry of 17,572 consecutive patients undergoing PCI at the University Health Network between April 2000 and December 2008. Patients were stratified according to age (< 85 years, n = 17,168, or ≥ 85 years, n = 404) and in-hospital mortality, major adverse cardiac events (MACE), and complication rates were calculated. Logistic regression-analysis identified independent predictors of unadjusted mortality and MACE. Very elderly patients were propensity matched with younger patients (1:2 ratio), and the analysis repeated.
Very elderly patients had a mean age of 87.5 ± 2.9 (range, 85-97 years) vs. 62.8 ± 11.1 years for the younger cohort and had a greater number of comorbid conditions. This cohort were more likely to present as an urgent or primary PCI, underwent more complex interventions, and achieved less angiographic success. Unadjusted mortality and post procedure myocardial infarction were significantly higher in very elderly patients (6.93% vs. 1.20%, P < 0.0001 and 4.46% vs. 2.74%, P = 0.04). Renal, neurological, and access-site complications were all greater in the very elderly cohort. Although age ≥ 85 years was a significant independent predictor of both mortality (OR, 2.62; CI, 1.44-4.78, P = 0.0016) and MACE (OR, 1.94; CI, 1.25-3.01, P = 0.003), other variables such as cardiogenic shock were more potent predictors of adverse outcomes.
Very elderly patients represent a high-risk cohort, with significantly increased in-hospital mortality and complication rates after PCI. Death occurred predominantly in very elderly patients undergoing nonelective PCI. Decisions to proceed with PCI in very elderly patients should be based on other prognostic variables in combination with advanced age, and these patients should not be excluded from revascularization based on age alone.
比较我院接受经皮冠状动脉介入治疗(PCI)的大量高龄患者(≥85 岁)与年轻患者(<85 岁)的住院结局。
介入心脏病学家由于认为高危患者预后较差,往往不愿对非常高龄患者进行 PCI。但是,高龄本身的预后意义尚不清楚。
将基础临床、血管造影和手术变量以及住院期间结局数据输入 2000 年 4 月至 2008 年 12 月在大学卫生网络接受 PCI 的 17572 例连续患者的前瞻性登记中。根据年龄(<85 岁,n=17168 或≥85 岁,n=404)分层,计算住院死亡率、主要不良心脏事件(MACE)和并发症发生率。使用逻辑回归分析确定未经调整死亡率和 MACE 的独立预测因素。将高龄患者与年轻患者(1:2 比例)进行倾向性匹配,并重复分析。
高龄患者的平均年龄为 87.5±2.9(范围 85-97 岁),而年轻患者为 62.8±11.1 岁。该队列更可能是紧急或直接 PCI,进行更复杂的干预,且血管造影成功率较低。高龄患者未经调整的死亡率和术后心肌梗死率明显更高(6.93% vs. 1.20%,P<0.0001 和 4.46% vs. 2.74%,P=0.04)。高龄患者的肾脏、神经和入路并发症均更高。尽管年龄≥85 岁是死亡率(OR,2.62;95%CI,1.44-4.78,P=0.0016)和 MACE(OR,1.94;95%CI,1.25-3.01,P=0.003)的独立显著预测因素,但心源性休克等其他变量是不良结局的更有力预测因素。
非常高龄患者是一个高危患者群体,PCI 后住院死亡率和并发症发生率显著增加。高龄患者的死亡主要发生在非择期 PCI 中。决定对高龄患者进行 PCI 应基于其他预后变量并结合高龄,不能仅因年龄而排除血运重建。